Donnie Rizzo: A major leap forward in the field of Digital Pathology and AI

Donnie Rizzo, Global Director at Pathology and Oncology at Quest Diagnostics, made the following post on LinkedIn:

“Exciting news! Today marks a major leap forward in the field of Digital Pathology and AI. With their potential to revolutionize precision medicine, I’m thrilled to announce our acquisition of PathAI Dx and our collaboration with PathAI. This partnership signifies our deep commitment to advancing healthcare through innovative technology. Together, we’re poised to unlock immense value for health systems, physicians, and most importantly, patients. Here’s to a future where technology enhances and saves lives.”

Additional information.
Source: Donnie Rizzo/LinkedIn
OncoDaily